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Abstract
Background: Bacillus thuringiensis Cry toxins are used worldwide in the control of different insect pests important in
agriculture or in human health. The Cry proteins are pore-forming toxins that affect the midgut cell of target insects. It was
shown that non-toxic Cry1Ab helix a-4 mutants had a dominant negative (DN) phenotype inhibiting the toxicity of wildtype
Cry1Ab when used in equimolar or sub-stoichiometric ratios (1:1, 0.5:1, mutant:wt) indicating that oligomer formation is a
key step in toxicity of Cry toxins.
Methodology/Principal Findings: The DN Cry1Ab-D136N/T143D mutant that is able to block toxicity of Cry1Ab toxin, was
used to analyze its capacity to block the activity against Manduca sexta larvae of other Cry1 toxins, such as Cry1Aa, Cry1Ac,
Cry1Ca, Cry1Da, Cry1Ea and Cry1Fa. Cry1Ab-DN mutant inhibited toxicity of Cry1Aa, Cry1Ac and Cry1Fa. In addition, we
isolated mutants in helix a-4 of Cry4Ba and Cry11Aa, and demonstrate that Cry4Ba-E159K and Cry11Aa-V142D are inactive
and completely block the toxicity against Aedes aegypti of both wildtype toxins, when used at sub-stoichiometric ratios,
confirming a DN phenotype. As controls we analyzed Cry1Ab-R99A or Cry11Aa-E97A mutants that are located in helix a-3
and are affected in toxin oligomerization. These mutants do not show a DN phenotype but were able to block toxicity when
used in 10:1 or 100:1 ratios (mutant:wt) probably by competition of binding with toxin receptors.
Conclusions/Significance: We show that DN phenotype can be observed among different Cry toxins suggesting that may
interact in vivo forming hetero-oligomers. The DN phenotype cannot be observed in mutants affected in oligomerization,
suggesting that this step is important to inhibit toxicity of other toxins.
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Introduction
Bacillus thuringiensis (Bt) bacteria produce insecticidal crystal (Cry)
proteins that are used in the control of insect pests important for
agricultural crops and against vectors of human diseases [1]. Cry
toxins have been characterized as pore-forming toxins. Their
mechanism of action involves specific interactions with several
receptors and insertion of part of the toxin into the apical
membrane of insect midgut cells, forming pores that finally kill the
larvae [2]. It was shown that Cry1A binding to cadherin receptor
induced the cleavage of an amino-terminal region including helix
a-1 leading to toxin oligomerization. Cry oligomers bind to
aminopeptidase or alkaline phosphatase receptors [3,4], and
inserts into the membrane to form toxic pores [1,2]. Helix a-3
of Cry toxin is involved in toxin oligomerization [5] and helix a-4
in membrane insertion and pore formation [6]. Mutants affected
in helices a-3 or a-4 are thus affected in pore formation activity
and completely lost toxicity against their target insect [5–7].
Recently it was reported that some non-toxic Cry1Ab helix a-4
mutants showed a dominant negative (DN) phenotype, since they
inhibited wildtype insecticidal activity at substochiometric ratios
[8]. These mutants were able to form homo-oligomers but were
affected in their pore formation activity and it was proposed that
monomers of the Cry1Ab-DN mutants are able to form oligomeric
structures with wildtype Cry1Ab functioning as effective antitoxins
that block toxicity of the wildtype toxin and then have the
potential to be use to protect special ecosystems from the potential
effects of Cry toxins on non-target insects [8]. Similar antitoxins
from different pore forming toxins that affect mammalian cells as
protective antigen PA subunit of anthrax toxin from Bacillus
anthracis [9,10], ClyA Cytotoxin from Escherichia coli [11] and
vacuolating toxin VacA from Helicobacter pylori [12] have also been
reported. DN inhibitors of PA, ClyA and VacA, are inactive
mutant-toxins that are able to form oligomer structures but are
affected in their pore formation activity. It was suggested that they
work as powerful inhibitors since they are able to co-assemble into
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oligomers together with their corresponding wildtype toxin
resulting in an effective inactivation of pore formation activity of
their wildtype toxins resulting in the complete loss of toxicity [9–
12]. In addition a dominant-negative mutant of HCN channels
present in the ventricular myocardium were also reported. The
nonfunctional HCN2 mutations affected pore formation of the
channel and suppressed HCN2 wildtype activity in a dominant-
negative manner [13]. In all these reports, the DN phenotype has
been regarded as compelling evidence for in vivo oligomer
formation and for this reason they were proposed as anti-toxins
to control the diseases that these bacterial-toxins induce in
mammalian organisms or to control arrhythmogenesis and cardiac
pacing [9–13].
Bt subsp. israelensis produce different Cry toxins (Cry4Aa,
Cry4Ba, Cry10Aa and Cry11Aa) that are active against mosquito
larvae [14]. It was proposed that mosquitocidal Cry toxins share a
similar mechanism of action with Cry1A toxins, that are active
against lepidopteran insect pests, since similar Cry-binding
molecules have been identified in mosquitoes, including cadherin
[15,16], aminopeptidase [17,18], and alkaline phosphatase [19].
Interestingly, several reports show a synergism between Cry11Aa
and Cry4Ba although the molecular mechanism of this synergistic
effect remains unknown [20–22]. Cry11A and Cry4Ba mutants in
helix a-4 were affected in toxicity against mosquito larvae [23,24].
In this work we used the previously described non-toxic
Cry1Ab-D136N/T143D mutant to analyze if its DN phenotype
extends to other Cry1 toxins. Cry1Ab-D136N/T143D was a
potent inhibitor of Cry1Ab in vivo and was affected in pore
formation but not in toxin-oligomerization [8]. We analyzed if this
DN-mutant was able to inhibit the toxicity of the highly related
Cry1Aa and Cry1Ac toxins and also of other Cry1 toxins that are
active against M. sexta (Cry1Ca, Cry1Da, Cry1Ea and Cry1Fa). In
addition we isolated helix a-4 mutants of Cry4Ba and Cry11Aa
and analyzed their DN phenotype with both wt Cry4Ba and
Cry11Aa toxins. Our results show that Cry1Ab DN mutant
functions as antitoxin of Cry1Aa, Cry1Ac and Cry1Fa, while
Cry11Aa and Cry4Ba DN mutants inhibit the toxicity of both
Cry11Aa and Cry4Ba toxins. These results suggest that in some
cases Bt Cry toxins have the potential to form hetero-oligomers.
Results
In vivo inhibition of toxin insecticidal activity
To compare the potency of the Cry1Ab helix a-4 mutant
D136N/T143D as DN inhibitor of other Cry1 toxins, we tested its
ability to inhibit the toxicity of other Cry1 toxins that are also
active against M. sexta such as Cry1Aa, Cry1Ac, Cry1Ca, Cry1Da,
Cry1Ea and Cry1Fa. We first determined the medium lethal
concentration (LC50 value) of each protoxin performing bioassays
against first instar M. sexta larvae using a series of different protoxin
concentrations (Table 1). Then we fed M. sexta larvae with
mixtures of Cry1Ab-D136N/T143D mutant with the different
wildtype Cry protoxins (at their corresponding LC50 concentra-
tion) in a protein ratio 0.5:1 (mutant:wildtype). Figure 1A shows
that Cry1Ab-D136N/T143D mutant blocked the action of
Cry1Aa, Cry1Ac and Cry1Fa toxins, but did not affect the
toxicity of Cry1Ca, Cry1D or Cry1Ea. The inhibition of toxicity of
Cry1Aa, Cry1Ac and Cry1Fa toxins by Cry1Ab-D136N/T143D
mutant was observed at sub-stoichiometric ratio.
We analyzed if the DN phenotype could be observed with a
different inactive mutant affected in oligomerization such as the
Cry1Ab-R99A located in helix a-3 of domain I [5]. Figure 1B
shows that this mutant did not have a DN phenotype, since it was
unable to inhibit the toxicity of the wildtype toxin when used a
sub-stoichiometric or equimolar ratios. In contrast, when we tested
higher concentrations of the Cry1Ab-R99A mutant, up to 10 or
100 fold higher concentration of the mutant than the wildtype
toxin; we found that Cry1Ab-R99A was able to inhibit toxicity of
wildtype toxin (Fig. 1B). This is probably due to binding
competition for toxin receptors since mutation of Cry1Ab-R99A
is located in helix a-3, a region that is not involved in toxin
interaction with receptors. These data suggest that binding
competition requires much higher concentrations of the compet-
itor, indicating a complete different mechanism than DN
phenotype.
Isolation of Cry4Ab and Cry11Aa mutants in helix a-4
As mentioned previously the mosquitocidal Cry11Aa and
Cry4Ba have a synergistic effect when fed together to certain
mosquito larvae [20–22]. In order to analyze if these toxins have a
similar mechanism of action than Cry1A toxins, we isolated four
mutants in helix a-4 of Cry4Ba (A145C, L152D, E159K and
R158A) and three mutants in Cry11Aa (N128D, Q135C and
V142D). Some of these mutants were highly susceptible to trypsin
degradation (Cry4Ba-A145C, Cry4Ba -R158A, Cry11Aa-N128D
and Cry11Aa-Q135C) and were not further analyzed. The crystal
inclusions of Cry4Ba-L152D, Cry4Ba-E159K and Cry11Aa-
V142D mutants were purified and protoxins activated with
trypsin, as described in materials and methods. Figure 2 shows
the SDS-PAGE electrophoretic profile of protoxins and activated
toxins of Cry4Ba and Cry11Aa mutant toxins analyzed in this
work. The Cry4Ba mutants produced a similar 40 and 18 kDa
activated toxin fragment as the wildtype and the Cry11Aa mutant
also showed a similar activation profile of 36 and 32 kDa as the
Cry11Aa, indicating no major effects in toxin structure stability.
The insecticidal activity of these wildtype and mutant proteins was
analyzed in bioassays against Aedes aegypti larvae as described, using
purified crystal suspensions that were sonicated to avoid
aggregation [25]. The Cry4Ba showed a lower LC50 value than
Cry11Aa toxin (Table 1). The Cry4Ba-L152D mutant was active
against A. aegypti while the mutants Cry4Ba-E159K and Cry11Aa-
V142D were inactive (Table 1). To test the ability of Cry4Ba-
E159K and Cry11Aa-V142D to inhibit the toxicity of their
corresponding wildtype toxins we used an equimolar (1:1) as well
Table 1. Toxicity of Cry toxins.
Protoxin
LC50
(95% fiducial limits) Target insect
Cry1Aa 3.7 (2.8–4.7)a Manduca sexta
Cry1Ab 2.9 (1.8–4.8)a Manduca sexta
Cry1Ac 1.8 (2.0–3.6)a Manduca sexta
Cry1Ca 52.5 (41.6–75.5)a Manduca sexta
Cry1Da 25.1 (19.9–44.1)a Manduca sexta
Cry1Ea 225.0 (190.1–280.8)a Manduca sexta
Cry1Fa 14.1 (8.2–22.3)a Manduca sexta
Cry4Ba 83.7 (55.4–130.2)b Aedes aegypti
Cry4Ba L152D 108.1 (79.2–190.4)b Aedes aegypti
Cry4Ba-E159K .2,000b Aedes aegypti
Cry11Aa 454.11 (312.7–760.6)b Aedes aegypti
Cry11Aa-V142D .2,000b Aedes aegypti
ang/cm2;
bng/ml.
doi:10.1371/journal.pone.0019952.t001
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as a lower ratio (0.5:1) of mutant:wildtype to fed the mosquito
larvae. Figure 1C shows that both mutant toxins were able to
block the action of their corresponding wildtype toxin showing a
DN phenotype since inhibition was observed at sub-stoichiometric
ratios. We finally analyzed if Cry4Ba-E159K was able to inhibit
the toxicity of Cry11Aa and if Cry11Aa-V142D could affect
toxicity of Cry4Ba against A. aegypti. Figure 1C shows that these
mutants blocked toxicity of a different wildtype toxin suggesting
that in vivo Cry11Aa and Cry4Ba toxins may interact in A. aegypti.
However, when we used the previously described non-toxic
Cry11Aa-E97A mutant, located in helix a-3 that is affected in
oligomerization [26], we found that this mutant did not show a
DN phenotype since it was unable to inhibit the toxicity of the
wildtype toxin when tested at 0.5:1 or 1:1 ratios. Similarly to the
data of Cry1Ab-R99A mutant described above, we found that
Cry11Aa-E97A mutant was able to block toxicity at 10:1 or 100:1
ratios (mutant:wt) suggesting that this inhibition is due to a different
mechanism, most probably involving binding competition.
Discussion
Inactive mutants of PA subunit of the anthrax toxin were
among the first reports of DN mutants in pore forming toxins.
These mutants were able to form oligomer structures but were
affected in their pore formation activity, working as powerful
inhibitors of anthrax toxin since they co-assemble into hetero-
Figure 1. In vivo analysis of the Dominant Negative phenotype of Cry mutants. Panel A, Toxicity assays against Manduca sexta larvae of
different Cry toxins at their corresponding LC50 concentration (see table 1) (black bars) and mixtures of Cry1Ab-D136N/T143D mutant with these
wildtype Cry toxins in a protein ratio 0.5:1 (mutant:wildtype) (white bars). Panel B, Toxicity assays against Manduca sexta or Aedes aegypti larvae of
Cry1Ab or Cry11Aa at their corresponding LC50 concentration (black bar) or in a mixture with Cry1Ab-R99E or Cry11Aa-E97A mutant toxins in a
protein ratio 1:1 (dashed bars), 10:1 (mutant:wildtype) (grey bars) or 100:1 (mutant:wildtype) (white bars). Panel C, Toxicity assays against Aedes
aegypti larvae of Cry4Ba or Cry11Aa at their corresponding LC50 concentration (black bar) or in a mixture with mutant toxins in a protein ratio 0.5:1
(mutant:wildtype) (white bars) or 1:1 (dashed bars).
doi:10.1371/journal.pone.0019952.g001
Figure 2. Analysis of Cry4Ba and Cry11Aa proteins in SDS-PAGE. Protoxins and trypsin-activated proteins were stained with Coomassie blue.
Molecular weight markers used in all SDS-PAGE were precision pre-stained plus standards all blue (BioRad, Hercules CA). Soluble protoxins are
Cry11Aa, E97A, V142D, Cry4Ba, L152D and E159K. Trypsin activated toxins are Cry11Aa-T, E97A-T, V142D-T, Cry4Ba-T, L152D-T and E159K-T.
doi:10.1371/journal.pone.0019952.g002
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oligomers with the wildtype toxin resulting in an effective inacti-
vation of pore formation and toxicity [9,10]. Similar results were
obtained with other pore forming toxins such as VacA and ClyA, and
in HCN ionic channels, where mutants affected in pore formation but
not in oligomerization also showed a DN phenotype [11–13]. It was
proposed that the underlying mechanism involves the hetero-
oligomerization between the mutant toxins with the wildtype
resulting in a DN effect, blocking the wildtype toxicity [9–13].
The mutant Cry1Ab-D136N/T143D in helix a-4, analyzed in
this study, was previously shown not to impair toxin assembly in a
pre-pore structure, but rather to block an essential conformational
transition of the assembled complex necessary for membrane
insertion and pore formation [8]. It was reported that this mutant
inhibited the activity of wildtype Cry1Ab in vivo against M. sexta
larvae and in vitro by analyzing pore formation in black lipid
bilayers [8].
In this work we hypothesized that if the DN phenotype of
Cry1Ab-D136N/T143D extends to different Cry toxins this could
suggests hetero-oligomerization among different Cry toxins. We
thus analyzed if the Cry1Ab-D136N/T143D mutant was capable
of blocking the toxicity of other Cry1 toxins when mixed at sub-
stoichiometric ratios.
Our data show that DN mutant of Cry1Ab was able to inhibit
toxicity of Cry1Aa, Cry1Ac and Cry1Fa toxins at 0.5:1 ratio
(mutant:wt). These data suggest that the molecular mechanism
observed in DN phenotype involves co-assembling between
different Cry toxin-monomers forming hetero-oligomeric struc-
tures. In addition, we isolated mutants in helix a-4 of Cry4Ba and
Cry11Aa toxins that are specific against mosquitoes. Some of these
mutants lost toxicity and also showed a clear DN phenotype when
mixed with their corresponding wildtype toxin. The DN
phenotype was also observed between the Cry4Ba-E159K mutant
and Cry11Aa or the Cry11Aa-V142D mutant and Cry4Ba
wildtype suggesting interaction between these two toxins. These
data resulted quite interesting since it was reported that Cry11Aa
and Cry4Ba have synergistic activity [19–21] showing in some
cases up to 10 fold higher activity in the mixture than the expected
mortality from the individual toxins.
Recently, a 3D-structure model of the Cry4Aa pre-pore
oligomer was published, based in the structure of the trimeric
unit cell of the X-ray crystal structure of the Cry4Ba toxin [27]. In
this structural model the authors proposed that the Cry4Aa
oligomer is stabilized by some residues of helices a-3, a-4 and a-6
and that pore formation may involved and insertion into the lipid
bilayer of the hairpin conformed by helices a-4 and a-5 of domain
I, while domains II and III remain in the membrane surface [27].
Comparison of amino acid sequences of helices a-3, a-4 and a-6
among the different Cry toxins used in this study did not revealed
any apparent explanation for the specificity of the DN phenotype,
indicating that primary sequence of these domain I regions do not
determine the binding interaction among different Cry toxins
and/or that other toxin regions are involved in this interactions,
this remains to be analyzed.
The role of toxin oligomerization in inducing the DN
phenotype was supported by the fact that Cry1Ab-R99A or
Cry11Aa-E97A mutants affected in the process of oligomerization
[5,26] did not induce a DN response since they were unable to
inhibit toxicity of their corresponding wildtype toxin at sub-
stoichiometric ratios neither at equimolar ratios. These data
strongly suggest that oligomerization among DN mutants and
wildtype monomers, represents the mechanism responsible of the
DN phenotype.
Our results show that helix a-3 mutants, Cry1Ab-R99A or
Cry11Aa-E97A, do not have a DN phenotype but inhibited
toxicity of their corresponding wt toxin when tested at higher
ratios such as 10:1 or 100:1 (mutant:wildtype), suggesting
competition for receptor binding. These data are similar to some
reported mutants of the anthrax toxin, since a PA mutant affected
in toxin oligomerization did not show a DN phenotype since it was
unable to form hetero-oligomers with the wildtype toxin [28].
However, this mutant still bound to, and competed, receptor
binding causing a competitive inhibition of anthrax toxin action at
10:1 ratio [28].
Although the physiological role of hetero-oligomerization
among different toxins remains to be analyzed, it is interesting
to note that synergism between different Cry toxins such as
Cry4Ba and Cry11Aa against mosquito larvae have been reported
[20–22]. The synergism between Cry1A toxins has been also
documented before. Specifically, Cry1Ab and Cry1Ac synergized
against Chilo partellus larvae showing up to five fold higher activity
when both toxins are present in the bioassay [29]. Also it was
reported that Cry1Aa and Cry1Ac have a synergistic effect against
Lymantria dispar larvae, increasing their toxicity up to 4.9 fold and
in this case voltage clamping assays demonstrated that combina-
tion of both toxins resulted in a greater pore formation activity
than the individual toxins [30]. In the case of Cry1A and Cry1Fa,
there are no data of synergism between them. However, when
both toxins were expressed in Bt-cotton plants, the control of
Helicoverpa zea and Spodoptera species was more effective than single
protein Bt-cotton plants [31]. Overall, these data may suggest that
synergistic effect could be related to the interaction of different Cry
toxins, forming a complex that is more effective in killing the target
larvae. Most Bt isolates produce more than one Cry toxin, thus, it
is tempting to speculate that hetero-oligomerization of Cry toxins
could have been selected in nature as a mechanism to modulate
toxicity and insect specificity of these family of pore-forming
toxins.
Materials and methods
Construction of Cry4Ba and Cry11Aa mutants
Mutants in helix a-4 of Cry4Ba (A145C, L152D, E159K and
R158A) and Cry11Aa (N128D, Q135C and V142D) were
produced by site-directed mutagenesis (Quick-Change, Strata-
gene, La Jolla, CA) using pCG6 plasmid [32] containing cry11Aa
gene or pHT611 plasmid [33] harboring the cry4Ba gene as
templates. Appropriate oligonucleotides were synthesized for each
mutant. Automated DNA sequencing at Instituto de Biotecnolo-
gı´a-UNAM’s facilities verified the single point mutations. Acrys-
talliferous Bt strain 407 was transformed with recombinant
plasmids as reported [34] and selected in Luria broth at 30uC
supplemented with 10 mg ml21 erythromycin.
Purification of Cry1, Cry4Ba and Cry11Aa toxins
The inclusion bodies of Cry1C, Cry1Da, Cry1Ea and Cry1Fa
protoxins were obtained as recombinant proteins expressed in
Escherichia coli as reported [35]. Cry1Aa, Cry1Ab and Cry1Ac were
produced in Bt bacteria as described [36]. Protoxins were
solubilized in alkaline buffer 50 mM Na2CO3, 0.2% b-mercap-
toethanol, pH 10.5.
Bt transformant strains of Cry4Ba and Cry11Aa proteins were
grown at 30uC in nutrient broth sporulation medium with
erythromycin until complete sporulation. Crystal inclusions were
purified by sucrose gradients [37]. Cry4Ba protoxin was
solubilized in alkaline buffer and activated with trypsin in a mass
ratio of 1:20 w/w trypsin/protoxin, for 4 h at 37uC. Cry11Aa was
solubilized in 100 mM NaOH, 1 h at 4uC. The pH was
equilibrated at pH 8.6 with same volume of 1M Tris HCl pH 8
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and activated with trypsin (1:50 w/w trypsin/protoxin) for 2 h at
25uC. Phenylmethylsulfonyl-fluoride (1 mM final concentration)
was added to stop proteolysis. Finally proteins were visualized in
SDS-PAGE gels stained with Coomassie blue. Molecular weight
markers were precision pre-stained plus standards all blue
(BioRad, Hercules CA).
Bioassays
Bioassays of Cry1A protoxins were performed with first instar
M. sexta larvae. Soluble protoxins (from 0.1 to 2000 ng/cm2) were
applied onto the diet surface of 24-well plates, using 24 larvae per
toxin concentration in triplicate. Protein was determined by the
Bradford assay. Mortality was recorded after seven days and lethal
concentration (LC50) value in ng of toxin per cm
2 of diet was
estimated by Probit (Polo-PC LeOra Software).
The bioassays of Cry4Ba and Cry11Aa against forth instar A.
aegypti larvae were done with purified crystal suspensions that were
sonicated to avoid aggregation [25]. Ten different concentrations
of purified crystals were used (50–6000 ng/mL) in 100 mL of
dechlorinated water containing 20 early fourth-instar larvae.
Negative control (dechlorinated water) was included in the
bioassay, and the viability of larvae was examined after 24 h.
The mean lethal concentration (LC50) was estimated as described
above. We used crystal suspensions due to the feeding behavior of
these larvae since they fed by filtering and then a soluble protoxin
is not toxic.
For DN assays different ratios of mutant:wildtype (0.5:1, 1:1,
10:1 and 100:1; w:w) were assayed. The concentration of wildtype
toxins used in DN-bioassays corresponds to the LC50 value of each
wt toxin as show in table 1.
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